Is Viavi Solutions Stock a Buy or Sell After Its CEO Sold Shares Worth $1.9 Million?

Viavi Solutions CEO Oleg Khaykin executed an open-market sale of 70,566 directly-held shares on Feb. 6, 2026 for roughly $1.9 million, leaving him with 1,708,871 direct shares and 40,238 indirect shares; the sale matched his median one-year sale size and involved no derivative or indirect transactions. The stock closed at $26.38 that day, up 106.1% over the prior 12 months and near a 52-week high, while Viavi reported TTM revenue of $1.24 billion and a TTM net loss of $41.7 million; fiscal Q2 sales were $369.3 million (up 36% YoY) with a $48.1 million loss but substantial improvement year-over-year. The transaction is presented as routine insider liquidity rather than a governance red flag, occurring amid significant share-price appreciation and improving operational results.

Analysis

Market structure: Viavi (VIAV) is a direct beneficiary of sustained carrier and fiber capex (5G/fiber/optical-security) and therefore benefits vendors and component suppliers; competitors with weaker product breadth (smaller test-tool vendors) are the primary losers. The CEO sale (70,566 shares, ~$1.9M) is tiny vs float and his remaining $45M direct stake, so immediate supply pressure is negligible, but the stock’s P/S ~5 and +106% YTD move imply expectations for continued revenue/margin expansion. Cross-asset: a revenue-driven beat would be modestly credit-positive (tighten CDS/credit spreads) and depress implied volatility; a miss could trigger a >10–20% equity repricing and spike option IV.

Risk assessment: Tail risks include a telecom capex slowdown, export/regulatory controls on optical tech, or a large customer contract loss that could force another multi-quarter loss; any of these could erase >30% market cap. Immediate (days) impact from this insider sale is immaterial; short term (weeks–months) Q3 results, customer contract announcements, or an unexpected insider sell program can move price ±15–30%; long term (2–4 quarters) the stock needs consistent GAAP profitability to justify current multiples. Hidden dependencies: concentrated telco customers and government optical contracts; catalysts to watch are large contract awards, buyback announcements, or change in insider sale cadence.

Trade implications: For risk-defined exposure, consider a tactical long size (1–2% portfolio) only on a retracement to $20–22 (≈15–25% downside from $26.38) with a hard stop at $18 and a 12-month target ~$35 (~+33%). If bullish but cost-sensitive, implement a 5–6 month bull-call spread (buy May 2026 $22 call / sell May 2026 $32 call) to cap premium and target the $30s. Income/neutral holders can sell short-dated covered calls (Mar–Apr 2026) at the $28 strike to collect ~5–7% premium while retaining upside; pairs: long VIAV vs short EXFO (1:1 notional) isolates share-of-wallet wins in test equipment.

Contrarian angle: The market treats this insider sale as routine, but consensus underweights execution risk: at P/S ~5 any revenue or margin miss is likely to be amplified. Historical parallels (post-5G vendor rallies) show sharp mean reversion when profitability lags — a reminder that momentum traders may be overexposed. Watch insider sale cadence: an increase above his one-year median (≈72k shares) over the next 60 days would be a material negative signal and actionable trigger to trim positions.

Key Decisions for Investors

• Establish a tactical long position in VIAV equal to 1–2% of portfolio only on a pullback to $20–22; set a stop-loss at $18 and a 12-month target of $35 (risk/reward ~+33% upside vs ~-18% downside).
• Buy a May 2026 bull-call spread: long May 2026 $22 call / short May 2026 $32 call sized to cap premium to ~1% portfolio risk; this expresses directional upside to $30s while limiting capital at risk.
• If holding VIAV into earnings, sell 1–3 month covered calls at the $28 strike (Mar–Apr 2026 expiries) to generate ~5–7% immediate yield and reduce short-term downside, rolling if calls are assigned on strong prints.
• Implement a relative-value pair: go long VIAV vs short EXFO (1:1 notional) sized to 0.5–1% net portfolio exposure to isolate share gains in network test/optical markets; close if the spread widens >15% or if VIAV reports sequential margin deterioration.
• Monitor insider sales cadence: if CEO sells exceed his one-year median (≈72k shares) in any 30–60 day window, reduce VIAV exposure by 50% — treat increased selling as a material negative signal.